Immunostimulating Interstitial Laser Thermotherapy

DEVICE5 trials

Sponsors

Clinical Laserthermia Systems AB, Universita di Verona

Conditions

Breast NeoplasmsMalignant MelanomaMelanomaNeoplasmsNeoplasms PancreaticPancreatic Cancer

Phase 1

Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)

CompletedNCT02702986

Universita di VeronaPancreatic Cancer

Start: 2016-02-29End: 2021-10-31Target: 10Updated: 2022-04-21

Unknown Phase

Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma

TerminatedNCT02650492

Clinical Laserthermia Systems ABMalignant Melanoma, Melanoma

Start: 2015-10-31End: 2019-05-01Updated: 2021-07-07

Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers

TerminatedNCT02690428

Clinical Laserthermia Systems ABNeoplasms

Start: 2016-02-29End: 2018-04-30Updated: 2019-01-30

Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer

CompletedNCT02973217

Clinical Laserthermia Systems ABNeoplasms Pancreatic

Start: 2016-10-31End: 2019-07-22Updated: 2020-12-17

Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer

TerminatedNCT03039127

Clinical Laserthermia Systems ABBreast Neoplasms

Start: 2016-06-30End: 2018-08-31Updated: 2021-07-07

Related Papers

Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies.

2020-12-0210 citations